Pfizer trial of cancer drug INLYTA is a failure

Korea |  News | By BioSpectrum Bureau  | 0 Comment | 22 Oct, 2012

Singapore: Pfizer has revealed that its phase III study of INLYTA (axitinib) did not meet the primary endpoint of demonstrating statistically significantly longer progression-free survival ...Read more

Korea to improvise Jordan healthcare system

Korea |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jul, 2014

Singapore: Korean International Cooperation Agency (KOICA) signed a memorandum of understanding with the Ministry of Health for establishment and expansion of health centers in Jordan. The ...Read more

Malaysian firm Duopharma forays into biosimilars

Korea |  News | By BioSpectrum Bureau  | 0 Comment | 01 Aug, 2012

Singapore: Malaysia's chemical company Duopharma has tied up with Korea's PanGen Biotech to pioneer a clinical trial of Erythropoietin (EPO) in Malaysia to treat end stage renal failure pat...Read more

AstraZeneca, KHIDI setup cancer research program

Korea |  News | By BioSpectrum Bureau  | 0 Comment | 11 Mar, 2014

Singapore: AstraZeneca signed a memorandum of understanding (MoU) with the Korea Health Industry Development Institute (KHIDI) to set up an oncology research programme. AstraZeneca will pro...Read more

US biosimilars market to be $9 bn by 2020

Korea |  News | By BioSpectrum Bureau  | 0 Comment | 03 Oct, 2012

Singapore: A new report by global business intelligence firm GBI Research has highlighted that the massive potential for pharmaceuticals in the US means that the country's biosimilars marke...Read more

Will RNL stem cell drug trial get Korean FDA nod?

Korea |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 12 Feb, 2013

Singapore: RNL Bio filed an Investigational New Drug (IND) application with the Korean Food and Drug Administration (KFDA) to start phase II and III clinical trials of RNL-Astrostem stem ce...Read more

Samsung to make Roche biologics at Korean plant

Korea |  News | By BioSpectrum Bureau  | 0 Comment | 24 Oct, 2013

Singapore: Samsung BioLogics and Roche have entered into a long term strategic manufacturing agreement under which Samsung will manufacture Roche's proprietary commercial biologic medicines...Read more

RNL to license stem cell technology to in Turkey

Korea |  News | By BioSpectrum Bureau  | 0 Comment | 14 Sep, 2012

Singapore: RNL Bio has signed the agreement with RST Biomedikal Sanayi, a Turkish company, to license RNL Bio's stem cell technology. RST as a licensee will pay the $5 million fee upfront ...Read more

Stem cells can help prevent Alzheimer's disease

Korea |  News | By BioSpectrum Bureau  | 0 Comment | 27 Sep, 2012

Singapore: In the first study of its kind, researchers at one of Korea's leading university and the RNL Bio Stem Cell Technology Institute have found that adult stem cells may not only have...Read more

F&S: Medical devices market highly fragmented

Korea |  News | By BioSpectrum Bureau  | 0 Comment | 11 Dec, 2012

Singapore: A new analysis from Frost & Sullivan, titled Medical Devices Distributor Profiling in Vietnam, Indonesia, Thailand and South Korea (VITSK), revealed that the medical devices ...Read more

BSA-CMR Survey: Oncology is the top therapeutic focus area for CROs in APAC

Korea |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

Stem cell hope for Parry-Romberg syndrome patients

Korea |  News | By BioSpectrum Bureau  | 1 Comment | 31 Aug, 2012

Singapore: Scientists of the RNL Stem Cell Technology Institute, Korea,  transplanted own stem cells of patients suffering from Parry-Romberg syndrome, thus dramatically improving the abil...Read more

Korea gearing up for biggest health convention

Korea |  News | By BioSpectrum Bureau  | 0 Comment | 14 May, 2014

Singapore: Even as big and emerging names continue to tie up with Korea's biggest international health convention, the event is all set to roll out the best achievements of the industry ove...Read more

INC Research expands in Korea to meet local demand

Korea |  News | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2012

Singapore: INC Research, a therapeutically focused clinical research organization (CRO) with a trusted process for delivering reliable results, opened a facility in South Korea to manage t...Read more

Taejoon eyes Korea top 10 list

Korea |  Influencers | By BioSpectrum Bureau  | 0 Comment | 16 May, 2012

Established in 1978, Taejoon Pharm has been a leading specialty pharma company in Korea in ophthalmology, contrast media and other sectors of the gastrointestinal area. Since 2002, the comp...Read more

Covidien gifts Korea a $21 mn medtech R&D center

Korea |  News | By BioSpectrum Bureau  | 0 Comment | 29 Aug, 2013

Singapore: Medical device developer, Covidien, has launched Covidien Center of Innovation Korea (CCI Korea), its first R&D, training and education center in Korea. With a total investme...Read more

BSA-CMR Survey: India, China lead in APAC CRO sector

Korea |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

Yaskawa Electric invests in ReWalk exoskeleton

Korea |  News | By BioSpectrum Bureau  | 0 Comment | 03 Oct, 2013

Singapore: Israel-based ARGO Medical Technologies has partnered with innovative robotics experts Yaskawa Electric, Japan, as it continues the global expansion of its ReWalk exoskeleton devi...Read more